DrugPatentWatch

What do you like best?

I've been using the DPW for years. I like best, and I'm grateful for: the responsiveness of the owner, Yali Friedman; the overtime expanding coverage of different modules; the flexible subscription plans (by module, by month, by year, etc.).

What do you dislike?

I would like it better when the extraction option for international data can be easier (currently I have to do it by country/region).

Recommendations to others considering the product:

My overall experience with DPW is very positive. I recommend you try it out and contact them when you have questions. The team is generally supportive and their features are growing over time. Since I am an independent researcher I use single-user license, but I would definitely recommend companies to use multi-person or team options.

What problems are you solving with the product? What benefits have you realized?

I am an academic entrepreneur, and I study economic issues in the biopharmaceutical industry. High quality and affordable data are extremely valuable to my research, and I thank the DPW for providing such services.